A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001
Clinical trial NCT04166669 · COMPLETED
Trial details
- NCT number
- NCT04166669
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-12
- Primary completion
- 2020-03-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.